Pricing Log in Create free account

Clene Inc. (CLNN) vs ImageneBio, Inc. (IMA)

Clene Inc. and ImageneBio, Inc. are both Biotechnology companies. Clene Inc. and ImageneBio, Inc. are of similar size ($47.0M and $45.7M). Clene Inc. grew revenue faster over the last twelve months: −31.1% against −68.0%. ImageneBio, Inc. has the higher net margin (0.00% vs −20,059.9%) and the lower return on invested capital (−622.4% vs 0.00%). Across the 17 metrics below, Clene Inc. leads on 9 and ImageneBio, Inc. on 8.

Valuation

Metric CLNN IMA Biotechnology median
P/E n/m n/m 8.50
P/S 194.86 10.63 9.71
P/B n/m 0.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 238.72 2.52 9.21
Earnings yield (112.90%) (129.11%) (33.15%)
Free cash flow yield (41.54%) (79.05%) (25.50%)

Profitability

Metric CLNN IMA Biotechnology median
Gross margin 70.05% 100.00% 65.16%
Operating margin (10,431.98%) 0.00% 0.00%
Net margin (20,059.90%) 0.00% 0.00%
Free cash flow margin (8,095.43%) 0.00% 0.00%
Return on equity 237.15% (41.34%) (56.36%)
Return on assets (174.99%) (38.34%) (48.04%)
Return on invested capital 0.00% (622.37%) 0.00%

Growth

Metric CLNN IMA Biotechnology median
Revenue growth (TTM) (31.12%) (67.95%) 6.02%
EPS growth (last fiscal year) 53.26% 21.27% 30.26%
Revenue growth, 5-year CAGR (0.59%) (38.64%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLNN IMA Biotechnology median
Debt to equity (0.74) 0.00 0.00
Current ratio 3.07 21.47 4.72
Net debt to EBITDA (0.39) 2.85 0.96

Dividend

Metric CLNN IMA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLNN IMA Biotechnology median
Market cap 46.98m 45.74m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack